Characterizing the landscape of pediatric immunization schedules in the US and Europe

Noah J Carr1, Alyson Haslam2

  • 1University of Arizona College of Medicine - Phoenix, Phoenix, AZ, USA. noahcarr@arizona.edu.

PubMed

Insights

Pediatric vaccine schedules show broad similarities across 32 countries, with most vaccines recommended universally. However, differences exist in vaccine mandates and timing, particularly for meningococcal, Hepatitis B, and COVID-19 vaccines.

Area of Science:

  • Public Health and Epidemiology
  • Pediatric Medicine
  • Immunization Policy

Background:

  • Pediatric immunizations are crucial for public health, reducing infectious diseases and infant mortality.
  • Limited research exists comparing international pediatric immunization schedules.
  • Understanding global vaccine recommendations is vital for public health strategies.

Purpose of the Study:

  • To systematically compare pediatric vaccine recommendations across 32 high-income countries in the US and Europe.
  • To identify similarities and differences in vaccine inclusion, dosing, and timing.
  • To characterize the landscape of general pediatric vaccine recommendations.

Main Methods:

  • Cross-sectional descriptive study analyzing publicly available pediatric vaccine schedules from 32 countries.
  • Included recommendations for healthy, non-pregnant children up to age 18.
  • Collected data on vaccine types, number of doses, and recommended ages for first vaccination.

Main Results:

  • 83.3% of identified vaccines were on at least one country's schedule; 45% were recommended by all 32 countries.
  • Total vaccines per schedule ranged from 11 to 18; 37.5% of countries had mandatory vaccinations.
  • Most vaccines had consistent dosing (84.2%) and first-dose timing, with exceptions for meningococcal, Hepatitis B, and COVID-19 vaccines.

Conclusions:

  • Pediatric immunization schedules exhibit significant commonalities in vaccine inclusion and dosing.
  • Notable variations persist in vaccine mandates and the timing of specific vaccinations.
  • Findings underscore the need for further research to inform evidence-based global immunization policies.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...